glaxosmithkline plc (GSK:London)
David S. Redfern
Chief Strategy Officer, GlaxoSmithKline plc
|Age||Total Calculated Compensation||This person is connected to 25 board members in 3 different organizations across 5 different industries.|
See Board Relationships
Mr. David S. Redfern has been the Chief Strategy Officer at GlaxoSmithKline plc since May 2008. Mr. Redfern is responsible for proactive exploration of new business opportunities and strategic planning of GlaxoSmithKline. He began his career with GSK in 1994 in Corporate Development and served as its Finance Director of Europe Pharmaceuticals since 1999. Previously, he served as Senior Vice President of Northern Europe and was responsible for managing GSK's pharmaceutical ...
980 Great West RoadPhone: 44 20 8047 5000
Brentford, Middlesex TW8 9GS
Board Members Memberships*
Chairman Of The Board
University of Bristol
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Giovanni Caforio M.D.||Chief Executive Officer and Director|
Bristol-Myers Squibb Company
|Omar S. Ishrak||Chairman and Chief Executive Officer|
|Robert J. Hugin MBA||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|Inge G. Thulin||Chairman, Chief Executive Officer and President|
|Richard A. Gonzalez||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|$1.6M||Compensation as of Fiscal Year 2014.|